Tag: Orphan drugs

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Orphan drugs

FDA Approves Injectable Opdivo for Many Types of Cancer

Added to Collection on: 2025-01-02 21:45:30

Tags for this article:

Orphan drugs
Cancer immunotherapy
Antineoplastic drugs
Immune system
Lung cancer
Checkpoint inhibitor
Nivolumab
Pembrolizumab
Atezolizumab
Small-cell carcinoma
Programmed cell death protein 1
Cancer treatment

Click the tags to see associated articles and topics

View Article Details
2024 FDA approvals - Nature

Added to Collection on: 2025-01-02 16:05:13

Tags for this article:

Antineoplastic drugs
Biotechnology
Cancer immunotherapy
Orphan drugs
Pharmaceutical industry
Antibody-drug conjugate
Targeted therapy
Biopharmaceutical
Elexacaftor/tezacaftor/ivacaftor
Pembrolizumab
CAR T cell
Gene therapy

Click the tags to see associated articles and topics

View Article Details
Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ...

Added to Collection on: 2025-01-06 19:47:42

Tags for this article:

Hepatology
Orphan drugs
Hepatocellular carcinoma
Angiogenesis inhibitors
Atezolizumab
Liver cancer
Bevacizumab
T-box transcription factor T
TIGIT
Bland embolization
Tempest Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Predictors of Rituximab Response in SSc-ILD - Physician's Weekly

Added to Collection on: 2025-01-06 14:07:54

Tags for this article:

Orphan drugs
Rituximab
C-reactive protein
Rheumatology

Click the tags to see associated articles and topics

View Article Details
Lennox Gastaut Syndrome Market Expected to rise, 2034 | GlaxoSmithKline, Meda ...

Added to Collection on: 2025-01-07 21:53:21

Tags for this article:

Anticonvulsants
Orphan drugs
Neurological disorders
Syndromes
Lennox?Gastaut syndrome
Epilepsy
Soticlestat
Lamotrigine
Lundbeck
Eisai
Myoclonus
LGS
Japan
United States
United Kingdom

Click the tags to see associated articles and topics

View Article Details
Lupus Nephritis Market Anticipated to Expand Rapidly During 2024-2034, Analyzes DelveInsight

Added to Collection on: 2025-01-08 22:28:23

Tags for this article:

Kidney diseases
Autoimmune diseases
Immunosuppressants
Cutaneous lupus erythematosus
Orphan drugs
Nephritis
Lupus nephritis
Lupus
Voclosporin
Mycophenolic acid
Obinutuzumab

Click the tags to see associated articles and topics

View Article Details
J&J says Rybrevant combo has survival edge over Tagrisso - pharmaphorum

Added to Collection on: 2025-01-08 15:19:53

Tags for this article:

Lung cancer
Orphan drugs
Acrylamides
Ethers
Tyrosine kinase inhibitors
Osimertinib
Amivantamab
Non-small-cell lung cancer
Epidermal growth factor receptor
Bispecific monoclonal antibody
T790M
Gefitinib
Johnson & Johnson
AstraZeneca
Johnson & Johnson's

Click the tags to see associated articles and topics

View Article Details
Blueprint Medicines Provides 2025 Outlook and Highlights Strategy for Continued Growth

Added to Collection on: 2025-01-12 21:42:39

Tags for this article:

Immune system disorders
Rare diseases
Mastocytosis
Orphan drugs
Tryptase
Medication
Avapritinib
Mast cell
Allergic conjunctivitis
Kate Haviland

Click the tags to see associated articles and topics

View Article Details
BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court

Added to Collection on: 2025-01-13 17:19:51

Tags for this article:

European Patent Organisation
Orphan drugs
BioMarin Pharmaceutical
Virotherapy
Vosoritide
Unitary patent
Medication
Patent
European Patent Office
European Patent Convention
BioMarin Pharmaceutical Inc.
Ascendis Pharma A/S
Ascendis Pharma

Click the tags to see associated articles and topics

View Article Details
Indian-origin CEO Aravind Srinivas backs US millionaire over quitting 'anti-aging' drug

Added to Collection on: 2025-01-14 15:10:48

Tags for this article:

Immunosuppressants
Macrolides
Polyenes
Orphan drugs
Lactams
Sirolimus
Perplexity AI
Bryan Johnson
Rapamycin

Click the tags to see associated articles and topics

View Article Details